Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,026 public trials 1,169 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Active, Not Recruiting

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

NCT04557449

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Breast Diseases, +33 more
Locations
  • Ellison Institute Los Angeles, California, United States
  • Smilow Cancer Hospital at Yale - New Haven New Haven, Connecticut, United States
  • Yale-New Haven Hospital-Yale Cancer Center New Haven, Connecticut, United States
  • Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET

NCT03993873

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Advanced Solid Tumor, +27 more
Locations
  • Local Institution - 2102 La Jolla, California, United States
  • Local Institution - 2108 Orange, California, United States
  • Local Institution - 2105 Denver, Colorado, United States
  • Local Institution - 2111 Chicago, Illinois, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors

NCT05393427

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • West China Hospital, Sichuan University Chengdu, Sichuan, China
View Trial Details
Active, Not Recruiting

A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors

NCT04606472

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +43 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
View Trial Details
Active, Not Recruiting

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

NCT03690388

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +13 more
Locations
  • Exelixis Clinical Site #2 Newport Beach, California, United States
  • Exelixis Clinical Site #98 Sacramento, California, United States
  • Exelixis Clinical Site #69 San Francisco, California, United States
  • Exelixis Clinical Site #10 Stanford, California, United States
View all 164 locations
View Trial Details
Active, Not Recruiting

A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma

NCT03635892

Conditions
Adenocarcinoma, Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Carcinoma, +20 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Active, Not Recruiting

AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)

NCT06245915

Conditions
Adenocarcinoma, Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Carcinoma, +19 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Iowa and Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View Trial Details

Related conditions